{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:44:32Z","timestamp":1781826272981,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen University Medicine Plus Program","award":["2024YG011"],"award-info":[{"award-number":["2024YG011"]}]},{"name":"Tianfu Jincheng Laboratory, Chengdu","award":["2025ZH047"],"award-info":[{"award-number":["2025ZH047"]}]},{"name":"HaiYa Young Scientist Foundation of Shenzhen University General Hospital","award":["2025-HY009"],"award-info":[{"award-number":["2025-HY009"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220530155611026"],"award-info":[{"award-number":["JCYJ20220530155611026"]}]},{"name":"Shenzhen Medical Research Fund","award":["D2403015"],"award-info":[{"award-number":["D2403015"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202311027]"],"award-info":[{"award-number":["SZSM202311027]"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515220068"],"award-info":[{"award-number":["2024A1515220068"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11908-6","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:27:35Z","timestamp":1778160455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuronal deletion of PDE7A averts morphine-induced behavioral plasticity and impairs downstream AKT signaling"],"prefix":"10.1007","volume":"53","author":[{"given":"Zizhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"1","key":"11908_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12888-019-2098-3","volume":"19","author":"M Fridell","year":"2019","unstructured":"Fridell M et al (2019) Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up. BMC Psychiatry 19(1):150. https:\/\/doi.org\/10.1186\/s12888-019-2098-3","journal-title":"BMC Psychiatry"},{"issue":"9","key":"11908_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/NMD.0b013e3182a2168a","volume":"201","author":"MB First","year":"2013","unstructured":"First MB (2013) Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis 201(9):727\u2013729. https:\/\/doi.org\/10.1097\/NMD.0b013e3182a2168a","journal-title":"J Nerv Ment Dis"},{"issue":"9","key":"11908_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock M et al (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11(9):1\u2013171. https:\/\/doi.org\/10.3310\/hta11090","journal-title":"Health Technol Assess"},{"issue":"16","key":"11908_CR4","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1111\/bph.13190","volume":"172","author":"F Noble","year":"2015","unstructured":"Noble F, Lenoir M, Marie N (2015) The opioid receptors as targets for drug abuse medication. Br J Pharmacol 172(16):3964\u20133979. https:\/\/doi.org\/10.1111\/bph.13190","journal-title":"Br J Pharmacol"},{"key":"11908_CR5","doi-asserted-by":"publisher","first-page":"108694","DOI":"10.1016\/j.neuropharm.2021.108694","volume":"196","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases. Neuropharmacology 196:108694. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108694","journal-title":"Neuropharmacology"},{"issue":"25","key":"11908_CR6","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.2174\/138161206778194123","volume":"12","author":"MA Giembycz","year":"2006","unstructured":"Giembycz MA, Smith SJ (2006) Phosphodiesterase 7A: a new therapeutic target for alleviating chronic inflammation? Curr Pharm Des 12(25):3207\u20133220. https:\/\/doi.org\/10.2174\/138161206778194123","journal-title":"Curr Pharm Des"},{"issue":"28","key":"11908_CR7","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1523\/jneurosci.3180-20.2021","volume":"41","author":"R Ciccocioppo","year":"2021","unstructured":"Ciccocioppo R et al (2021) Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission. J Neurosci 41(28):6128\u20136143. https:\/\/doi.org\/10.1523\/jneurosci.3180-20.2021","journal-title":"J Neurosci"},{"issue":"2","key":"11908_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0893-133X(02)00290-7","volume":"27","author":"E Acquas","year":"2002","unstructured":"Acquas E, Tanda G, Di G, Chiara (2002) Differential Effects of Caffeine on Dopamine and Acetylcholine Transmission in Brain Areas of Drug-naive and Caffeine-pretreated Rats. Neuropsychopharmacology 27(2):182\u2013193. https:\/\/doi.org\/10.1016\/S0893-133X(02)00290-7","journal-title":"Neuropsychopharmacology"},{"key":"11908_CR9","doi-asserted-by":"publisher","unstructured":"Listos J et al (2019) The mechanisms involved in morphine addiction: an overview. Int J Mol Sci 20(17). https:\/\/doi.org\/10.3390\/ijms20174302","DOI":"10.3390\/ijms20174302"},{"key":"11908_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.pmbts.2015.10.005","volume":"137","author":"P Chan","year":"2016","unstructured":"Chan P, Lutfy K (2016) Molecular changes in opioid addiction: the role of adenylyl cyclase and cAMP\/PKA system. Prog Mol Biol Transl Sci 137:203\u2013227. https:\/\/doi.org\/10.1016\/bs.pmbts.2015.10.005","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"8","key":"11908_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/s2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760\u2013773. https:\/\/doi.org\/10.1016\/s2215-0366(16)00104-8","journal-title":"Lancet Psychiatry"},{"key":"11908_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","volume":"69","author":"SM DeWire","year":"2007","unstructured":"DeWire SM et al (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483\u2013510. https:\/\/doi.org\/10.1146\/annurev.physiol.69.022405.154749","journal-title":"Annu Rev Physiol"},{"key":"11908_CR13","doi-asserted-by":"publisher","first-page":"110655","DOI":"10.1016\/j.pnpbp.2022.110655","volume":"120","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) Neuronal lack of PDE7a disrupted working memory, spatial learning, and memory but facilitated cued fear memory in mice. Prog Neuropsychopharmacol Biol Psychiatry 120:110655. https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110655","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"11908_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcma.2013.09.008","volume":"77","author":"W-W Liao","year":"2014","unstructured":"Liao W-W et al (2014) Coadministration of glycogen-synthase kinase 3 inhibitor with morphine attenuates chronic morphine-induced analgesic tolerance and withdrawal syndrome. J Chin Med Association 77(1):31\u201337. https:\/\/doi.org\/10.1016\/j.jcma.2013.09.008. .DOI","journal-title":"J Chin Med Association"},{"issue":"2","key":"11908_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1124\/jpet.104.066548","volume":"310","author":"DL Muller","year":"2004","unstructured":"Muller DL, Unterwald EM (2004) In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 310(2):774\u2013782","journal-title":"J Pharmacol Exp Ther"},{"issue":"36","key":"11908_CR16","doi-asserted-by":"publisher","first-page":"23534","DOI":"10.1074\/jbc.273.36.23534","volume":"273","author":"RD Polakiewicz","year":"1998","unstructured":"Polakiewicz RD et al (1998) \u00b5-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273(36):23534\u201323541","journal-title":"J Biol Chem"},{"issue":"9","key":"11908_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1021\/acschemneuro.0c00106","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y et al (2020) PDE-7 Inhibitor BRL-50481 reduces neurodegeneration and long-term memory deficits in mice following sevoflurane exposure. ACS Chem Neurosci 11(9):1353\u20131358. https:\/\/doi.org\/10.1021\/acschemneuro.0c00106","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"11908_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.neuron.2014.11.007","volume":"84","author":"P Su","year":"2014","unstructured":"Su P et al (2014) A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects. Neuron 84(6):1302\u20131316. https:\/\/doi.org\/10.1016\/j.neuron.2014.11.007","journal-title":"Neuron"},{"issue":"2","key":"11908_CR19","doi-asserted-by":"publisher","first-page":"e17240","DOI":"10.1371\/journal.pone.0017240","volume":"6","author":"JA Morales-Garcia","year":"2011","unstructured":"Morales-Garcia JA et al (2011) Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS ONE 6(2):e17240. https:\/\/doi.org\/10.1371\/journal.pone.0017240","journal-title":"PLoS ONE"},{"key":"11908_CR20","doi-asserted-by":"publisher","first-page":"135470","DOI":"10.1016\/j.neulet.2020.135470","volume":"741","author":"G Chen","year":"2021","unstructured":"Chen G et al (2021) Phosphorylation of GluN2B subunits of N-methyl-d-aspartate receptors in the frontal association cortex involved in morphine-induced conditioned place preference in mice. Neurosci Lett 741:135470. https:\/\/doi.org\/10.1016\/j.neulet.2020.135470","journal-title":"Neurosci Lett"},{"issue":"3","key":"11908_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1017\/s1461145713001429","volume":"17","author":"YT Wang","year":"2014","unstructured":"Wang YT et al (2014) Chaperone heat shock protein 70 in nucleus accumbens core: a novel biological target of behavioural sensitization to morphine in rats. Int J Neuropsychopharmacol 17(3):469\u2013484. https:\/\/doi.org\/10.1017\/s1461145713001429","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"11908_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","volume":"24","author":"WN Arifin","year":"2017","unstructured":"Arifin WN, Zahiruddin WM (2017) Sample size calculation in animal studies using resource equation approach. Malays J Med Sci 24(5):101\u2013105. https:\/\/doi.org\/10.21315\/mjms2017.24.5.11","journal-title":"Malays J Med Sci"},{"key":"11908_CR23","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139020879","volume-title":"Statistical Principles for the Design of Experiments: Applications to Real Experiments","author":"R Mead","year":"2012","unstructured":"Mead R, Gilmour SG, Mead A (2012) Statistical principles for the design of experiments: applications to real experiments. Cambridge Series in Statistical and Probabilistic Mathematics. Cambridge University Press, Cambridge"},{"issue":"1","key":"11908_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13041-019-0445-4","volume":"12","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Conditioned stimulus presentations alter anxiety level in fear-conditioned mice. Mol Brain 12(1):28. https:\/\/doi.org\/10.1186\/s13041-019-0445-4","journal-title":"Mol Brain"},{"key":"11908_CR25","doi-asserted-by":"publisher","unstructured":"Huang Y et al (2021) Inhibiting PDE7A enhances the protective effects of neural stem cells on neurodegeneration and memory deficits in sevoflurane-exposed mice. eNeuro 8(4). https:\/\/doi.org\/10.1523\/eneuro.0071-21.2021","DOI":"10.1523\/eneuro.0071-21.2021"},{"key":"11908_CR26","doi-asserted-by":"publisher","unstructured":"Knott EP et al (2017) Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair. Int J Mol Sci 18(4). https:\/\/doi.org\/10.3390\/ijms18040696","DOI":"10.3390\/ijms18040696"},{"issue":"4","key":"11908_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/cns.12834","volume":"24","author":"A Cardinale","year":"2018","unstructured":"Cardinale A, Fusco FR (2018) Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington\u2019s disease. CNS Neurosci Ther 24(4):319\u2013328. https:\/\/doi.org\/10.1111\/cns.12834","journal-title":"CNS Neurosci Ther"},{"key":"11908_CR28","doi-asserted-by":"publisher","first-page":"1019187","DOI":"10.3389\/fnagi.2022.1019187","volume":"14","author":"J Sheng","year":"2022","unstructured":"Sheng J et al (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci 14:1019187. https:\/\/doi.org\/10.3389\/fnagi.2022.1019187","journal-title":"Front Aging Neurosci"},{"issue":"22","key":"11908_CR29","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.1074\/jbc.M601333200","volume":"281","author":"P Han","year":"2006","unstructured":"Han P et al (2006) PDE7A1, a cAMP-specific phosphodiesterase, inhibits camp-dependent protein kinase by a direct interaction with C*. J Biol Chem 281(22):15050\u201315057. https:\/\/doi.org\/10.1074\/jbc.M601333200","journal-title":"J Biol Chem"},{"issue":"1","key":"11908_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","volume":"59","author":"SS Taylor","year":"1990","unstructured":"Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 59(1):971\u20131005","journal-title":"Annu Rev Biochem"},{"key":"11908_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0079-6603(08)60718-7","volume":"63","author":"M Conti","year":"1999","unstructured":"Conti M, Jin SL (1999) The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 63:1\u201338. https:\/\/doi.org\/10.1016\/s0079-6603(08)60718-7","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"11908_CR32","doi-asserted-by":"publisher","first-page":"806618","DOI":"10.3389\/fncel.2021.806618","volume":"15","author":"J Jones-Tabah","year":"2021","unstructured":"Jones-Tabah J et al (2021) The Signaling and Pharmacology of the Dopamine D1 Receptor. Front Cell Neurosci 15:806618. https:\/\/doi.org\/10.3389\/fncel.2021.806618","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"11908_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1389450110607011421","volume":"7","author":"RS Jope","year":"2006","unstructured":"Jope RS, Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7(11):1421\u20131434. https:\/\/doi.org\/10.2174\/1389450110607011421","journal-title":"Curr Drug Targets"},{"issue":"49, 2009","key":"11908_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","volume":"49","author":"J-M Beaulieu","year":"2009","unstructured":"Beaulieu J-M, Gainetdinov RR, Caron MG (2009) Akt\/GSK3 Signaling in the Action of Psychotropic Drugs. Annu Rev Pharmacol Toxicol 49(49, 2009):327\u2013347. https:\/\/doi.org\/10.1146\/annurev.pharmtox.011008.145634","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"50","key":"11908_CR35","doi-asserted-by":"publisher","first-page":"20732","DOI":"10.1073\/pnas.1215489109","volume":"109","author":"NM Urs","year":"2012","unstructured":"Urs N.M. et al (2012) Deletion of GSK3\u03b2 in D2R-expressing neurons reveals distinct roles for \u03b2-arrestin signaling in antipsychotic and lithium action. Proc Natl Acad Sci 109(50):20732\u201320737. https:\/\/doi.org\/10.1073\/pnas.1215489109","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"11908_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","volume":"11","author":"HY Meltzer","year":"2011","unstructured":"Meltzer HY, Massey BW (2011) The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 11(1):59\u201367. https:\/\/doi.org\/10.1016\/j.coph.2011.02.007","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"11908_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","volume":"132","author":"J-M Beaulieu","year":"2008","unstructured":"Beaulieu J-M et al (2008) A \u03b2-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior. Cell 132(1):125\u2013136. https:\/\/doi.org\/10.1016\/j.cell.2007.11.041","journal-title":"Cell"},{"issue":"2","key":"11908_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-013-0039-0","volume":"27","author":"GS Malhi","year":"2013","unstructured":"Malhi GS et al (2013) Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs 27(2):135\u2013153. https:\/\/doi.org\/10.1007\/s40263-013-0039-0","journal-title":"CNS Drugs"},{"issue":"9878","key":"11908_CR39","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","volume":"381","author":"JR Geddes","year":"2013","unstructured":"Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381(9878):1672\u20131682. https:\/\/doi.org\/10.1016\/S0140-6736(13)60857-0","journal-title":"Lancet"},{"issue":"2","key":"11908_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/cn300182g","volume":"4","author":"JA Morales-Garc\u00eda","year":"2013","unstructured":"Morales-Garc\u00eda JA et al (2013) Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease. ACS Chem Neurosci 4(2):350\u2013360. https:\/\/doi.org\/10.1021\/cn300182g","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"11908_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2013.07.010","volume":"141","author":"MK King","year":"2014","unstructured":"King MK et al (2014) Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacol Ther 141(1):1\u201312. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.010","journal-title":"Pharmacol Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11908-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11908-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:27:37Z","timestamp":1778160457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11908-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11908"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11908-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were carried out according to the protocols approved by the Institutional Animal Care and Use Committee of Peking University Shenzhen Graduate School.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"724"}}